The rise of Viagra and its impact on the drug landscape presents a intricate question for traders. While the initial sales data were impressive, the patent has expired, leading to a flood of copycat alternatives that are chipping away at earnings. In addition, the market is facing difficulties related to demographic trends and evolving healthcare r